GLP-1 microdosing is the medical practice of administering very small doses of a drug, often to provide dose-specific benefits that might be different than the regular dose, while minimizing side effects
Many require referrals, multiple in-person visits, and lengthy insurance approvals that leave consumers frustrated and discouraged
Laakso J, Mervaala E, Himberg JJ, et al
Obviously, genetics cannot be changed, but if there is a will - coupled with commitment - then anyone, even you can change your shape
Although the role of APLAs in the pathogenesis of MS is not clear, given that MS is associated with an increased risk of thrombosis and cardiovascular events (see, for example, [18, 20, 21]), MS patients with APLAs may benefit from anticoagulation or ASA treatment